Oncology center plans FM location
FORT MOHAVE — Dr. Gordon L. Grado, medical director of Southwest Oncology Centers, has announced plans to establish a Fort Mohave/Bullhead City Cancer Center.
The center follows the purchase of medical office space that will be converted to accommodate a new, state-of-the-art Varian Linear Accelerator that has been acquired for installation. The equipment and technology will bring the latest in radiation therapy services and treatment options for patients in the Tri-state.
Southwest Oncology Centers is the oldest dedicated radiation oncology-based cancer program in Arizona, founded by Dr. Frank Danziger in 1983. Grado took over the program in 1999.
The Fort Mohave/Bullhead City facility will be Southwest’s fourth cancer center in Arizona, joining sister locations in Scottsdale, Glendale and Yuma.
In mid-November, Southwest Oncology Centers will embark on a joint project with Kingman Regional Medical Center to provide radiation therapy services in Kingman.
Grado recently became aware that a group of medical oncologists previously working in the Bullhead City area was closing its practice. He said it was clear that the latest in radiation oncology services and other technologies were not available in the area and patients were having to be referred to larger cities such of Phoenix or Las Vegas to receive more complex external beam or internal radiation services.
Grado and the physicians at Southwest Oncology Centers reached the conclusion that a facility was needed in northwest Arizona and it began a search for a suitable location to meet the needs for a cancer center capable of providing all radiation therapy services.
The medical office at 5263 Highway 95 in Fort Mohave was purchased and plans are to modify the building to accommodate the equipment and technology necessary to provide those services.
Grado stated he is going to be bringing a team of radiation oncology specialists to create specialty clinics in radiation for treatment of prostate, breast, lung, head and neck, gynecological and brain cancers.
An expected opening date will be announced in the future.